McKesson Corporation (NYSE:MCK) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

MCKESSON CORP Exhibit
EX-99.1 2 d591815dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 SUPPLEMENTAL HISTORICAL SEGMENT FINANCIAL INFORMATION We are furnishing to investors supplemental historical financial information by new reportable segment for our quarterly and annual results of fiscal 2018 as well as annual results for fiscal 2017 and 2016. We believe the presentation of our historical segment financial information by new reportable segment provides useful supplemental information to investors to better understand the impact of segment changes. The executive who was our segment manager of the Distribution Solutions segment retired from the Company in January 2018. As a result,…
To view the full exhibit click here

About McKesson Corporation (NYSE:MCK)

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.